Airway diseases
Thoracic oncology
Clinical trials session
ALERT 4: Asthma and interventional pulmonology
Clinical
Aims : Including the ALERT sessions (Abstracts Leading to Evolution in Respiratory Medicine Trials), these formats showcase important and very late-breaking clinical trial data from all respiratory disease areas. Presenters, session chairs and viewers will take part lively discussions on the presented trials.
Methods :
General respiratory patient care, Surgery, Imaging, Endoscopy and interventional pulmonology
16:00
Tezepelumab reduces mucus plugging in patients with uncontrolled, moderate-to-severe asthma: the phase 2 CASCADE study
C. Brightling(Leicester (Leicestershire), United Kingdom)
COI
1
16:07
Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma: The INCA Sun randomized clinical trial
R. Costello(Dublin 9, Ireland)
COI
2
16:14
Wrap-up by discussant and discussion
G. Brusselle(Ghent, Belgium)
COI
3
RCT4447
16:29
Comparative Effect of Lung volume reduction surgery for Emphysema and Bronchoscopic lung volume reduction with valve placement: the CELEB trial.
S. Buttery(London, United Kingdom)
COI
4
16:36
Sustained health-related quality of life in patients with severe heterogenous emphysema treated with spiration valve system at 24-month follow-up (EMPROVE)
G. Criner(Philadelphia, United States)
COI
5
16:43
Wrap-up by discussant and discussion
I. Opitz(Zurich, Switzerland)
COI
6
RCT4450
16:58
A randomized controlled trial evaluating the benefit of cone beam CT guidance to electromagnetic navigation bronchoscopy for the diagnosis of pulmonary nodule
B. Bondue(Bruxelles, Belgium)
COI
7
17:05
Endosonography with or without confirmatory mediastinoscopy for resectable lung cancerA randomized clinical trial
J. Annema(Amsterdam, Netherlands)
COI
8
17:12
Wrap-up by discussant and discussion
I. Opitz(Zurich, Switzerland)
COI
9
RCT4453
17:27
Closing remarks
10
RCT4454
. . .
